{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:02Z","timestamp":1790516162680,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00535-017-1308-3","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T01:50:21Z","timestamp":1485222621000},"page":"1081-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial"],"prefix":"10.1007","volume":"52","author":[{"given":"Takashi","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Sei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Watari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,24]]},"reference":[{"key":"1308_CR1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","volume":"54","author":"J Dent","year":"2005","unstructured":"Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710\u20137.","journal-title":"Gut"},{"key":"1308_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1572-0241.2005.00343.x","volume":"101","author":"I Wiklund","year":"2006","unstructured":"Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol. 2006;101:18\u201328.","journal-title":"Am J Gastroenterol."},{"key":"1308_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000080308","volume":"22","author":"I Wiklund","year":"2004","unstructured":"Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis. 2004;22:108\u201314.","journal-title":"Dig Dis"},{"key":"1308_CR4","first-page":"656","volume":"2","author":"BB Dean","year":"2004","unstructured":"Dean BB, Gano AD Jr, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2004;2:656\u201364.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc."},{"key":"1308_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gut.38.5.649","volume":"38","author":"RH Holloway","year":"1996","unstructured":"Holloway RH, Dent J, Narielvala F, et al. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut. 1996;38:649\u201354.","journal-title":"Gut"},{"key":"1308_CR6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.pain.2011.02.019","volume":"152","author":"T Miki","year":"2011","unstructured":"Miki T, Matsunami M, Nakamura S, et al. ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis. Pain. 2011;152:1373\u201381.","journal-title":"Pain"},{"key":"1308_CR7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1046\/j.1460-9568.1999.00602.x","volume":"11","author":"T Minami","year":"1999","unstructured":"Minami T, Okuda-Ashitaka E, Hori Y, et al. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur J Neurosci. 1999;11:1849\u201356.","journal-title":"Eur J Neurosci."},{"key":"1308_CR8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00000539-200110000-00043","volume":"93","author":"H Kawahara","year":"2001","unstructured":"Kawahara H, Sakamoto A, Takeda S, et al. A prostaglandin E2 receptor subtype EP1 receptor antagonist (ONO-8711) reduces hyperalgesia, allodynia, and c-fos gene expression in rats with chronic nerve constriction. Anesth Analg. 2001;93:1012\u20137.","journal-title":"Anesth Analg"},{"key":"1308_CR9","doi-asserted-by":"crossref","first-page":"G568","DOI":"10.1152\/ajpgi.00276.2012","volume":"304","author":"T Kondo","year":"2013","unstructured":"Kondo T, Oshima T, Tomita T, et al. Prostaglandin E(2) mediates acid-induced heartburn in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2013;304:G568\u201373.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1308_CR10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cgh.2015.01.014","volume":"13","author":"T Kondo","year":"2015","unstructured":"Kondo T, Oshima T, Tomita T, et al. The nonsteroidal anti-inflammatory drug diclofenac reduces acid-induced heartburn symptoms in healthy volunteers. Clin Gastroenterol Hepatol. 2015;13:1249\u201355.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1308_CR11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340:1888\u201399.","journal-title":"N Engl J Med."},{"key":"1308_CR12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1023\/A:1018834301901","volume":"43","author":"V Savarino","year":"1998","unstructured":"Savarino V, Mela GS, Zentilin P, et al. Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. Dig Dis Sci. 1998;43:459\u201363.","journal-title":"Dig Dis Sci"},{"key":"1308_CR13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.bjp.0704092","volume":"133","author":"T Minami","year":"2001","unstructured":"Minami T, Nakano H, Kobayashi T, et al. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol. 2001;133:438\u201344.","journal-title":"Br J Pharmacol"},{"key":"1308_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1172\/JCI6749","volume":"107","author":"JL Stock","year":"2001","unstructured":"Stock JL, Shinjo K, Burkhardt J, et al. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Investig. 2001;107:325\u201331.","journal-title":"J Clin Investig"},{"key":"1308_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0304-3959(01)00276-7","volume":"92","author":"Z Zhang","year":"2001","unstructured":"Zhang Z, Hefferan MP, Loomis CW. Topical bicuculline to the rat spinal cord induces highly localized allodynia that is mediated by spinal prostaglandins. Pain. 2001;92:351\u201361.","journal-title":"Pain"},{"key":"1308_CR16","first-page":"597","volume":"10","author":"A Hall","year":"2007","unstructured":"Hall A, Billinton A, Giblin GM. EP1 antagonists for the treatment of inflammatory pain. Curr Opin Drug Discov Dev. 2007;10:597\u2013612.","journal-title":"Curr Opin Drug Discov Dev"},{"key":"1308_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bmcl.2008.11.032","volume":"19","author":"A Hall","year":"2009","unstructured":"Hall A, Brown SH, Budd C, et al. Discovery of GSK345931A: an EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain. Bioorg Med Chem Lett. 2009;19:497\u2013501.","journal-title":"Bioorg Med Chem Lett"},{"issue":"144","key":"1308_CR18","doi-asserted-by":"crossref","first-page":"S-134","DOI":"10.1016\/S0016-5085(13)60486-2","volume":"5","author":"T Konemura","year":"2013","unstructured":"Konemura T, Date I, Fujii Y, et al. 746 ONO-8539, a novel prostanoid ep1 receptor antagonist, suppresses acid-induced primary and secondary esophageal hypersensitivity in monkeys. Gastroenterology. 2013;5(144):S-134.","journal-title":"Gastroenterology."},{"key":"1308_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/gast.2003.50022","volume":"124","author":"S Sarkar","year":"2003","unstructured":"Sarkar S, Hobson AR, Hughes A, et al. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology. 2003;124:18\u201325.","journal-title":"Gastroenterology"},{"key":"1308_CR20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-2036.2009.04142.x","volume":"30","author":"R Jones","year":"2009","unstructured":"Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"1308_CR21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/apt.12204","volume":"37","author":"C Jonasson","year":"2013","unstructured":"Jonasson C, Wernersson B, Hoff DA, et al. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2013;37:564\u201372.","journal-title":"Aliment Pharmacol Ther"},{"key":"1308_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2050640613485238","volume":"1","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Matsuzaki J, Okada S, et al. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United Eur Gastroenterol J. 2013;1:175\u201383.","journal-title":"United Eur Gastroenterol J."},{"key":"1308_CR23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888\u201391.","journal-title":"J Gastroenterol"},{"key":"1308_CR24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","volume":"10","author":"RB Fillingim","year":"2009","unstructured":"Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain Off J Am Pain Soc. 2009;10:447\u201385.","journal-title":"J Pain Off J Am Pain Soc"},{"key":"1308_CR25","first-page":"901","volume":"90","author":"P Nguyen","year":"1995","unstructured":"Nguyen P, Lee SD, Castell DO. Evidence of gender differences in esophageal pain threshold. Am J Gastroenterol. 1995;90:901\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1308_CR26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00535-012-0665-1","volume":"48","author":"T Yamasaki","year":"2013","unstructured":"Yamasaki T, Oshima T, Tomita T, et al. Effect of age and correlation between esophageal visceral chemosensitivity and mechanosensitivity in healthy Japanese subjects. J Gastroenterol. 2013;48:360\u20135.","journal-title":"J Gastroenterol"},{"key":"1308_CR27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00535-009-0047-5","volume":"44","author":"Y Fujiwara","year":"2009","unstructured":"Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518\u201334.","journal-title":"J Gastroenterol"},{"key":"1308_CR28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1569-9056(10)60760-9","volume":"9","author":"DMT Wilbraham","year":"2010","unstructured":"Wilbraham DMT, Deacon S, Kuwayama T, Vincent S. Safety, tolerability and pharmacokinetic of multiple ascending doses of the EP-1 receptor antagonist ONO-8539, a potential new and novel therapy to overactive bladder in healthy young and elderly subjects. Eur Urol. 2010;9:250.","journal-title":"Eur Urol"},{"key":"1308_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.juro.2013.08.082","volume":"191","author":"CR Chapple","year":"2014","unstructured":"Chapple CR, Abrams P, Andersson KE, et al. Phase II study on the efficacy and safety of the EP1 receptor antagonist ONO-8539 for nonneurogenic overactive bladder syndrome. J Urol. 2014;191:253\u201360.","journal-title":"J Urol."},{"key":"1308_CR30","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0016-5085(98)70014-9","volume":"115","author":"R Fass","year":"1998","unstructured":"Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115:1363\u201373.","journal-title":"Gastroenterology"},{"key":"1308_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(78)90020-9","volume":"5","author":"RH Gracely","year":"1978","unstructured":"Gracely RH, McGrath F, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain. 1978;5:5\u201318.","journal-title":"Pain"},{"key":"1308_CR32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.gastro.2003.11.047","volume":"126","author":"RP Willert","year":"2004","unstructured":"Willert RP, Woolf CJ, Hobson AR, et al. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-d-aspartate receptor. Gastroenterology. 2004;126:683\u201392.","journal-title":"Gastroenterology"},{"key":"1308_CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2036.2011.04955.x","volume":"35","author":"YC Chua","year":"2012","unstructured":"Chua YC, Ng KS, Sharma A, et al. Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers\u2014a placebo-controlled study. Aliment Pharmacol Ther. 2012;35:319\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"1308_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2036.2011.04918.x","volume":"35","author":"T Oshima","year":"2012","unstructured":"Oshima T, Okugawa T, Tomita T, et al. Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects. Aliment Pharmacol Ther. 2012;35:175\u201382.","journal-title":"Aliment Pharmacol Ther"},{"key":"1308_CR35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2036.2007.03367.x","volume":"26","author":"H Miwa","year":"2007","unstructured":"Miwa H, Nakajima K, Yamaguchi K, et al. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26:257\u201364.","journal-title":"Aliment Pharmacol Ther"},{"key":"1308_CR36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2036.2003.01745.x","volume":"18","author":"T Scholten","year":"2003","unstructured":"Scholten T, Gatz G, Hole U. Once-daily pantoprazole 40\u00a0mg and esomeprazole 40\u00a0mg have equivalent overall efficacy in relieving GERD-related symptoms. Aliment Pharmacol Ther. 2003;18:587\u201394.","journal-title":"Aliment Pharmacol Ther"},{"key":"1308_CR37","first-page":"276","volume":"109","author":"S Wellek","year":"2012","unstructured":"Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109:276\u201381.","journal-title":"Dtsch Arztebl Int."},{"key":"1308_CR38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1572-0241.2004.04171.x","volume":"99","author":"J Tack","year":"2004","unstructured":"Tack J, Koek G, Demedts I, et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett\u2019s esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol. 2004;99:981\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1308_CR39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrgastro.2013.50","volume":"10","author":"E Savarino","year":"2013","unstructured":"Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10:371\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"1308_CR40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gut.2007.127886","volume":"57","author":"CH Knowles","year":"2008","unstructured":"Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut. 2008;57:674\u201383.","journal-title":"Gut"},{"key":"1308_CR41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1572-0241.1999.00925.x","volume":"94","author":"S Rodriguez-Stanley","year":"1999","unstructured":"Rodriguez-Stanley S, Robinson M, Earnest DL, et al. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol. 1999;94:628\u201331.","journal-title":"Am J Gastroenterol."},{"key":"1308_CR42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","volume":"58","author":"R Fass","year":"2009","unstructured":"Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009;58:295\u2013309.","journal-title":"Gut"},{"key":"1308_CR43","doi-asserted-by":"crossref","first-page":"532594","DOI":"10.1155\/2014\/532594","volume":"2014","author":"K Takeuchi","year":"2014","unstructured":"Takeuchi K, Nagahama K. Animal model of acid-reflux esophagitis: pathogenic roles of acid\/pepsin, prostaglandins, and amino acids. BioMed Res Int. 2014;2014:532594.","journal-title":"BioMed Res Int"},{"key":"1308_CR44","first-page":"588","volume":"89","author":"J Sarosiek","year":"1994","unstructured":"Sarosiek J, Yu Z, Namiot Z, et al. Impact of acid and pepsin on human esophageal prostaglandins. Am J Gastroenterol. 1994;89:588\u201394.","journal-title":"Am J Gastroenterol."},{"key":"1308_CR45","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","volume":"137","author":"RF Souza","year":"2009","unstructured":"Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776\u201384.","journal-title":"Gastroenterology"},{"key":"1308_CR46","doi-asserted-by":"crossref","first-page":"G695","DOI":"10.1152\/ajpgi.00162.2015","volume":"309","author":"L Wu","year":"2015","unstructured":"Wu L, Oshima T, Shan J, et al. PAR-2 activation enhances weak acid-induced ATP release through TRPV1 and ASIC sensitization in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2015;309:G695\u2013702.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1308_CR47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/nmo.12342","volume":"26","author":"T Kondo","year":"2014","unstructured":"Kondo T, Oshima T, Koseki J, et al. Effect of rikkunshito on the expression of substance P and CGRP in dorsal root ganglion neurons and voluntary movement in rats with experimental reflux esophagitis. Neurogastroenterol Motil. 2014;26:913\u201321.","journal-title":"Neurogastroenterol Motil"},{"key":"1308_CR48","first-page":"579","volume":"22","author":"T Oshima","year":"2010","unstructured":"Oshima T, Koseki J, Sakurai J, et al. NK-1 receptor is involved in the decreased movement in a rat chronic acid reflux oesophagitis model. Neurogastroenterol Motil. 2010;22:579\u201384, e125.","journal-title":"Neurogastroenterol Motil"},{"key":"1308_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10620-012-2308-z","volume":"58","author":"X Xu","year":"2013","unstructured":"Xu X, Li Z, Zou D, et al. High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease. Dig Dis Sci. 2013;58:53\u201360.","journal-title":"Dig Dis Sci"},{"key":"1308_CR50","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s10620-012-2337-7","volume":"58","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Kuroda M, Suzuki T, et al. Role of nociceptors\/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease. Dig Dis Sci. 2013;58:2237\u201343.","journal-title":"Dig Dis Sci"},{"key":"1308_CR51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1471-4159.2010.06927.x","volume":"115","author":"W Ma","year":"2010","unstructured":"Ma W. Chronic prostaglandin E2 treatment induces the synthesis of the pain-related peptide substance P and calcitonin gene-related peptide in cultured sensory ganglion explants. J Neurochem. 2010;115:363\u201372.","journal-title":"J Neurochem"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1308-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T17:13:01Z","timestamp":1505927581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1308-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,24]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1308-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,24]]}}}